The availability of blood and blood components used for therapeutic purposes is dependent largely on Community citizens who are prepared to donate. In order to safeguard public health and to prevent the transmission of infectious diseases, all precautionary measures during their collection, processing, distribution and use need to be taken making appropriate use of scientific progress in the detection and inactivation and elimination of transfusion transmissible pathogenic agents.
Recital 2, Directive (EU) 2002/98
Judgment of the Court (First Chamber), 13 March 2014. Octapharma France SAS v Agence nationale de sécurité du médicament et des produits de Decision
Recitals 2, 3, and 5 in the preamble to Directive 2002/98 state: The availability of blood and blood components used for therapeutic purposes is dependent largely on Community citizens who are prepared to donate. In order to safeguard …
13 Mar 2014 · 62012CJ0512
Opinion of Advocate General Mengozzi delivered on 17 July 2014. Geoffrey Léger v Ministre des Affaires sociales, de la Santé et des Droits dDecision
Its adoption is part of a context in which the Member States had previously experienced failings in their systems for monitoring and securing the transfusion chain. Consequently, the supranational authorities took up the matter, at the …
17 Jul 2014 · 62013CC0528
Judgment of the Court (Fourth Chamber) of 29 April 2015. Geoffrey Léger v Ministre des Affaires sociales, de la Santé et des Droits des femmDecision
Recitals 1, 2, 24 and 29 in the preamble to Directive 2002/98 state: The extent to which human blood is used therapeutically demands that the quality and safety of whole blood and blood components be ensured in order to prevent in …
29 Apr 2015 · 62013CJ0528
Judgment of the Court (Third Chamber) of 8 June 2017. Medisanus d.o.o. v Splošna Bolnišnica Murska Sobota.Decision
According to recitals 2, 4, 23 and 32 of Directive 2002/98, which governs various operations in relation to human blood: The availability of blood and blood components used for therapeutic purposes is dependent largely on Community …
8 Jun 2017 · 62015CJ0296
Opinion of Advocate General Saugmandsgaard Øe delivered on 1 December 2016. Medisanus d.o.o. v Splošna Bolnišnica Murska Sobota.Decision
As emphasised in recital 2 of Directive 2002/98, the availability of blood and blood components used for therapeutic purposes is dependent largely on Community citizens who are prepared to donate.
1 Dec 2016 · 62015CC0296
Opinion of Advocate General Jääskinen delivered on 7 November 2013. Octapharma France SAS v Agence nationale de sécurité du médicament et deDecision
It is true that Directive 2002/98 contains no express exception with respect to plasma prepared by methods involving an industrial process, and that its Article 2(1) refers to both ‘collection and testing’ and ‘their processing, …
7 Nov 2013 · 62012CC0512